Impact of Impaired Renal Function on Gadolinium Retention After Administration of Gadolinium-Based Contrast Agents in a Mouse Model.
The aim of this study was to investigate the impact of impaired renal function on gadolinium (Gd) retention in various organs after Gd-based contrast agent injection.



After local animal care and review committee approval, 23 normal mice and 26 with renal failure were divided into 4 treatment groups (Gd-DTPA-BMA, 5 mmol/kg; Gd-DOTA, 5 mmol/kg; GdCl3, 0.02 mmol/kg; and saline, 250 μL). Each agent was intravenously administered on weekdays for 4 weeks. Samples were collected on days 3 (short-term) and 45 (long-term) after the last injection. Gadolinium concentrations were quantified by inductively coupled plasma-mass spectrometry.



Three mice with renal failure and 2 normal mice in the GdCl3 group and 1 mouse with renal failure in the Gd-DTPA-BMA group died. In the Gd-DTPA-BMA group, impaired renal function increased short-term Gd retention in the liver, bone, spleen, skin, and kidney (P < 0.01) but did not affect long-term Gd retention. Gd-DTPA-BMA showed higher Gd retention than Gd-DOTA. Although Gd retention in the Gd-DOTA group was generally low, impaired renal function increased only long-term hepatic Gd retention. Hepatic and splenic Gd retentions were significantly higher than other organs' Gd retention in the GdCl3 group (P < 0.01). Renal function did not affect brain Gd retention, regardless of the Gd compound used.



The tendency of Gd retention varied according to the agent, regardless of renal function. Although renal impairment increased short-term Gd retention after Gd-DTPA-BMA administration, long-term Gd retention for Gd-based contrast agents was almost unaffected by renal function, suggesting that the chemical structures of retained Gd may not be consistent and some Gd is slowly eliminated after initially being retained.
From the *Department of Radiology Diagnostic and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan; †Department of Nuclear Medicine and Molecular Imaging, Universitas Padjajaran, Bandung, Indonesia; ‡Department of Public Health, Gunma University and §Gunma University Initiative for Advance Research (GIAR), Maebashi, Gunma, Japan.
A Adhipatria P
AA
Kartamihardja
Takahito
T
Nakajima
Satomi
S
Kameo
Hiroshi
H
Koyama
Yoshito
Y
Tsushima
D000818:Animals; D003287:Contrast Media / Q000378:metabolism*; D004195:Disease Models, Animal; D005260:Female; D005682:Gadolinium / Q000378:metabolism*; D007668:Kidney / Q000503:physiopathology*; D013058:Mass Spectrometry; D051379:Mice; D051437:Renal Insufficiency / Q000503:physiopathology*
D003287:Contrast Media; D005682:Gadolinium